VACCINE CULT going insane because CDC plans to review USELESSNESS of injecting newborn babies with toxic Hep-B jab for sexually transmitted disease

Ask yourself, even if you don’t have children, why in the world would the medical “community” push a vaccine for sexually transmitted diseases on newborn babies? Vaccines are the most dangerous form of medicine, as most contain known carcinogens, neurotoxins, and heavy metal toxins that disrupt and destroy the brain, the central nervous system, and the immune system. So, where’s the reasoning?

The Centers for Disease Control and Prevention’s (CDC) recent announcement that it will review and reconsider its decades-old recommendation for universal newborn hepatitis B (Hep B) vaccination has set off strong reactions across mainstream media. Outlets such as MedPage Today rushed to defend the vaccine, portraying it as both safe and necessary, while critics argue the policy lacks medical justification for low-risk infants.

• The CDC’s Advisory Committee on Immunization Practices (ACIP), led by Martin Kulldorff, announced it may revisit the longstanding recommendation that every newborn receive the hepatitis B (Hep B) vaccine, sparking pushback from mainstream outlets like MedPage Today, which defended the shot as safe and necessary.
• Critics argue that Hep B primarily affects IV drug users and those at high risk, not most newborns, and that mothers can be screened for infection — raising questions about the necessity of universal vaccination at birth.
• Concerns have also been raised about the safety of the vaccine, including its aluminum content and past CDC data suggesting links between thimerosal-containing vaccines and autism, though those findings were downplayed or dismissed in published reports.
• The Hep B vaccine was added to the childhood immunization schedule in 1991 after pharmaceutical companies gained liability protection through the National Vaccine Injury Compensation Program, shifting the CDC’s strategy from targeting high-risk groups to mass infant vaccination despite low U.S. prevalence.

CDC plan to review Hep B vaccine for babies sends mainstream media into tailspin

The controversy began at the CDC’s June meeting of the Advisory Committee on Immunization Practices (ACIP), led by Martin Kulldorff, Ph.D., a former Harvard epidemiologist appointed by U.S. Health Secretary Robert F. Kennedy Jr. Kulldorff questioned the wisdom of administering the vaccine to all newborns when the primary U.S. risk groups for hepatitis B are IV drug users and individuals with multiple sexual partners. He emphasized that, unless a mother is hepatitis B positive, vaccination could reasonably be delayed. ACIP also announced new work groups to examine the cumulative impact of the childhood vaccine schedule and to review vaccines that have gone unexamined for more than seven years, including Hep B.

Mainstream outlets quickly condemned this move. MedPage Today argued that reopening the debate could undermine public trust in a vaccine credited with eliminating childhood HBV transmission in the U.S. The publication quoted infectious disease specialists who insisted the vaccine is essential to preventing liver disease and cancer. Critics, however, point out that the vaccine does not directly prevent cancer, but rather prevents HBV, which in some cases can lead to liver cancer.

Skepticism about the universal newborn policy stems from the fact that hepatitis B prevalence in the U.S. is low, estimated at 0.6 percent. Approximately 25,000 pregnant women annually are infected, and only about 1,000 transmit the virus to their babies. Critics argue that routine maternal screening would make universal newborn vaccination unnecessary. Nevertheless, the CDC requires children to be vaccinated against Hep B for school or daycare attendance in nearly every state.

Safety concerns also remain a flashpoint. The vaccine contains at least 250 micrograms of aluminum, an adjuvant that critics claim is linked to autism and neurological harm. Historical CDC data obtained through Freedom of Information Act requests by Safe Minds appear to show an elevated autism risk in infants exposed to thimerosal-containing vaccines, including Hep B. Internal CDC emails from lead investigator Thomas Verstraeten revealed struggles to dismiss the apparent connection, with successive re-analyses reducing or eliminating the risks before final publication.

Questions also surround how Hep B vaccination became mandatory for children. Initially, in the 1980s, the CDC only recommended it for high-risk groups, including healthcare workers and babies born to infected mothers. By 1988, the agency called for universal maternal screening. That same year, Congress established the National Vaccine Injury Compensation Program (VICP), shielding manufacturers from liability for vaccine injuries once a vaccine was added to the childhood schedule. In 1991, despite no significant change in prevalence, ACIP broadened its recommendations, declaring universal infant vaccination the “most effective” means of preventing HBV transmission.

Today, the CDC’s review signals the first serious reexamination of the Hep B policy in decades. The outcome could reignite debate over vaccine mandates, medical freedom, and the balance between public health priorities and individual risk. Bookmark Vaccines.news to your favorite independent websites for updates on experimental gene therapy injections that give babies autism and Long-Vax-Syndrome.

Sources for this article include:

NaturalNews.com

ChildrensHealthDefense.org

Healio.com

MedPageToday.com

CHOP.edu